HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage tolerance. Zong B, Sun L, Peng Y, Wang Y, et al. Oncol Rep 2021;46.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zong B, Sun L, Peng Y, Wang Y, et al. HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage tolerance. Oncol Rep 2021;46.
PMID: 34036395